Drugs / muscle derived stem cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02156934 | Jan 2014 → Dec 2015 | female stress incontinence | Royan Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | muscle derived stem cell | “Paraurethral injection of muscle derived stem cell in patients with stress urine incontinency.” NCT02156934 ↗ |
| Modality | Cell therapy | “autologous muscle derived cells as therapy for stress urinary incontinence” NCT02156934 ↗ |
| Route | Other | “Paraurethral injection” NCT02156934 ↗ |